NeuroFrontiers
Clinical research and advancements furthering clinicians’ ability to diagnose and treat neurological disorders never stop. And neither does NeuroFrontiers, a series dedicated to covering them all. Here neurology specialists will find essential updates on conditions affecting the nervous system, spinal cord, and overall brain health.
So if you want to stay up to date on the latest clinical research and news on neurological disorders, then look no further. Because NeuroFrontiers is where neurology specialists and great minds explore the mind itself.
Episodes 211-225 of 338
Practices for Preventing Polypharmacy in Multiple Sclerosis
NeuroFrontiersPractices for Preventing Polypharmacy in Multiple Sclerosis
From Assessment to Management: Tackling Catatonia in Schizophrenic Patients
NeuroFrontiersFrom Assessment to Management: Tackling Catatonia in Schizophrenic Patients
How Alzheimer's and Lewy Body Pathology Impact CAA Risk Factors
NeuroFrontiersHow Alzheimer's and Lewy Body Pathology Impact CAA Risk Factors
Advancements in Multiple Sclerosis: Insights from the 2024 ACTRIMS Forum
NeuroFrontiersAdvancements in Multiple Sclerosis: Insights from the 2024 ACTRIMS Forum
Exploring the Latest in MS Cognitive Rehabilitation Strategies
NeuroFrontiersExploring the Latest in MS Cognitive Rehabilitation Strategies
Visionary Insights: Assessing MS-Related Retinal Changes with Adaptive Optics
NeuroFrontiersVisionary Insights: Assessing MS-Related Retinal Changes with Adaptive Optics
- advertisement
Family Planning Clinical Considerations for Patients with Multiple Sclerosis
NeuroFrontiersFamily Planning Clinical Considerations for Patients with Multiple Sclerosis
Unmet Needs in Rehabilitation Research for Multiple Sclerosis
NeuroFrontiersUnmet Needs in Rehabilitation Research for Multiple Sclerosis
MS Research: Using Epigenetic Clocks and Biomarkers to Assess Biological Aging
NeuroFrontiersMS Research: Using Epigenetic Clocks and Biomarkers to Assess Biological Aging
Telehealth in MS Care: Addressing the Potential for Improvement and Concerns
NeuroFrontiersTelehealth in MS Care: Addressing the Potential for Improvement and Concerns
Addressing Healthcare Barriers in Patients with Multiple Sclerosis
NeuroFrontiersAddressing Healthcare Barriers in Patients with Multiple Sclerosis
Toxic Short RNAs May Cause Neuronal Cell Death in Alzheimer’s Disease
NeuroFrontiersToxic Short RNAs May Cause Neuronal Cell Death in Alzheimer’s Disease
- advertisement
Schizophrenia Diagnosis: The Importance of a Collaborative Approach
NeuroFrontiersSchizophrenia Diagnosis: The Importance of a Collaborative Approach
Examining the Role of Toxic Tau Proteins in Alzheimer's Disease
NeuroFrontiersExamining the Role of Toxic Tau Proteins in Alzheimer's Disease
New Study Shows EBV-Specific T-Cells Contribute to MS Development
NeuroFrontiersNew Study Shows EBV-Specific T-Cells Contribute to MS Development
